Magnesium forms differ in the compounds that carry the mineral, their solubility, and how particular preparations perform in absorption studies. Some comparisons favor citrate over oxide. That does not create a universal ranking for every formulation or every person—and greater absorption in a study is not automatically a better health outcome. Compare elemental magnesium first, then ask what evidence actually supports the form. [1] [2] [3]

A person comparing two labels at a wooden table.

The same mineral, different companions

Magnesium citrate pairs magnesium with citrate; magnesium oxide combines it with oxygen. Magnesium bisglycinate is a chelate involving glycine, while L-threonate is another magnesium salt. These names identify different chemical preparations. They do not, on their own, specify the amount of magnesium delivered or establish a particular benefit. [1] [4] [5]

The number to compare on Supplement Facts is elemental magnesium. The mass of the complete compound includes more than magnesium. If a front label displays a compound weight, do not compare it directly with another label’s elemental amount. [1]

What the comparisons actually show

Form What can be said What should not be inferred
Citrate Human studies have found greater absorption-related measures than with the oxide preparations tested. That citrate wins every comparison or produces better sleep or other outcomes. [2] [3]
Oxide It performed less well in several specific absorption studies. That all oxide preparations have one fixed absorption percentage, or that none is absorbed. [6]
Glycinate / bisglycinate A small diglycinate trial explored absorption after intestinal surgery. That chelation establishes universal superiority or a proven special transport route in everyone. [4]
L-threonate Animal research and human placebo-controlled trials address particular preparations and outcomes. That it is established as the best-absorbed magnesium or is superior to other forms for everyone. [7] [8]

In a 1990 comparison, citrate was more soluble in laboratory conditions, and healthy volunteers had a larger rise in urinary magnesium after citrate than after oxide. A 2003 trial in 46 healthy participants also found differences favoring citrate on several measures. These are useful findings about the tested preparations and measurements—not direct demonstrations of a noticeable benefit in daily life. [2] [3]

“Organic” versus “inorganic” is not a sufficient shortcut either. A 2001 study found greater absorption-related results with chloride, lactate, and aspartate than with its oxide preparation. Chloride is an inorganic salt. A broad chemical category does not replace a comparison of the actual preparations. [6]

Be careful with the chelation story

A frequently cited 1994 diglycinate study involved 12 people who had undergone ileal resection. Overall absorption did not differ between diglycinate and oxide in the group as a whole. A subgroup of 4 participants with the poorest oxide absorption showed a difference favoring the chelate. The authors suggested that some diglycinate might be absorbed intact through a dipeptide pathway. That suggestion and that population should travel with the claim. [4]

Removing those details changes the meaning. “A small study suggested a pathway” is not equivalent to “this form bypasses the usual absorption process in everyone.” The word chelated describes the preparation; a universal mechanism still needs evidence.

Human evidence is not the same as a head-to-head test

Early L-threonate research included experiments in rats. Human trials have since been published, so it would also be misleading to say that only animal evidence exists. A 2024 study compared L-threonate with placebo for 21 days in 80 adults with self-reported sleep problems. A study in the 2025 journal volume, published online in January 2026, compared a specific L-threonate preparation with placebo for 6 weeks in 100 adults. [5] [7] [8]

A 2025 correction states that the 2024 trial was registered after it was completed and supplies previously omitted competing-interest details. Both trials received industry funding. Registration timing and sponsor involvement belong alongside the findings when judging their strength. [9] [8]

The 2026 trial reported differences on some measures but not on others, including no between-group differences in the sleep outcomes measured by its wearable device. Neither of these trials compared L-threonate against citrate, oxide, or bisglycinate. They therefore cannot settle a ranking among those forms. [7] [8]

What is still unsettled

These studies differ in participants, preparations, duration, and measurement. Urinary magnesium, blood measurements, questionnaires, and wearable estimates are not interchangeable endpoints. Tolerability also matters, and an absorption comparison does not establish that a particular person needs supplementation. [1] [3] [7]

A useful comparison names the form, elemental amount, exact preparation, population, and outcome measured. If a claim leaves out most of those details, treat it as a question to investigate—not a finished answer.

Sources & reading notes

Research papers are linked to their PubMed records. Official guidance is linked to the publishing institution. These sources explain the subject; they do not evaluate a Monovits product.

  1. Magnesium — Health Professional Fact Sheet
    NIH Office of Dietary Supplements · Accessed 2026-09-14

    Official overview of magnesium amounts, forms and evidence. Used here for label literacy and context, not a product recommendation.

    Back to first citation
  2. Magnesium bioavailability from magnesium citrate and magnesium oxide.
    Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. · 1990 · PMID 2407766 · DOI 10.1080/07315724.1990.10720349

    Compared solubility and urinary magnesium after citrate and oxide. It did not measure improvements in sleep or other daily-life outcomes.

    Back to first citation
  3. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study.
    Walker AF, Marakis G, Christie S, Byng M. · 2003 · PMID 14596323

    A 60-day study in 46 healthy participants, using urine, blood and saliva measures. These are absorption-related measurements, not proof of a noticeable benefit.

    Back to first citation
  4. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection.
    Schuette SA, Lashner BA, Janghorbani M. · 1994 · PMID 7815675 · DOI 10.1177/0148607194018005430

    A crossover study in 12 people after ileal resection. The overall absorption comparison was not different; a subgroup result should not be generalized to everyone.

    Back to first citation
  5. Enhancement of learning and memory by elevating brain magnesium.
    Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B, Zhao X, Govindarajan A, Zhao MG, Zhuo M, Tonegawa S, Liu G. · 2010 · PMID 20152124 · DOI 10.1016/j.neuron.2009.12.026

    Animal experiments involving rats.

    Back to first citation
  6. Bioavailability of US commercial magnesium preparations.
    Firoz M, Graber M. · 2001 · PMID 11794633

    Compared four commercial preparations using urinary magnesium. Its results are not a universal absorption percentage for every formulation.

    Back to first citation
  7. Magnesium L-threonate and sleep quality: a randomized controlled trial
    Hausenblas HA, Lynch T, Hooper S, Shrestha A, Rosendale D, Gu J. · 2024 · PMID 39252819 · DOI 10.1016/j.sleepx.2024.100121

    A 21-day industry-funded placebo-controlled study in 80 adults. A 2025 correction reports retrospective registration and previously omitted competing interests. It did not compare L-threonate against other magnesium forms.

    Back to first citation
  8. Magnesium L-threonate, cognition and sleep: a placebo-controlled trial
    Lopresti AL, Smith SJ. · 2026 · PMID 41601871 · DOI 10.3389/fnut.2025.1729164

    A 6-week industry-funded placebo-controlled study in 100 adults. The funder helped conceptualise the study design and supplied the study preparation. Results differed across endpoints; wearable sleep measures showed no between-group difference.

    Back to first citation
  9. Correction to the 2024 magnesium L-threonate sleep trial
    Hausenblas HA, Lynch T, Hooper S, Shrestha A, Rosendale D, Gu J. · 2025 · PMID 40567408 · DOI 10.1016/j.sleepx.2025.100141

    The trial was retrospectively registered on April 15, 2024. The correction also discloses that its sponsor commissioned and funded the study, owns patents, and paid three authors. The authors state that the protocol was not changed after the trial began.

    Back to first citation

Educational information, not individual medical advice. This article does not evaluate or endorse a supplement product.